D-2HG accumulates in certain brain tumors, such as gliomas and glioblastomas, with gain-of-function mutations in the IDH1 and IDH2 genes encoding the IDH1 and IDH2 enzymes, respectively [10,62,65,123,124,125]. This evidence concerns the gene IDH2 and central nervous system cancer.